Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Truncated Bcl-2, a potential pre-metastatic marker in prostate cancer.

Biochemical and biophysical research communications - 11 Jul 2003

Huang Jen-Ming, Lin Tsen-Yin, Chang Donald, Lin Shi-Lung, Ying Shao-Yao

Abstract excerpt

A novel truncated form of Bcl-2, termed Bcl-2psi, was discovered in invasive prostate cancer cells, using laser capture microdissection, RNA-polymerase cycling reaction, and microarray analysis. The expression of Bcl-2psi increased prior to metastasis in higher-grade prostate cancer. The immunoreactive Bcl-2psi was specifically identified in higher-grade prostate cancer cells. These findings suggest that Bcl-2psi...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blotting, Northern
Share to Dissection
Share to Gene Library

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lasers

Share to Neoplasm Metastasis

Share to Prostatic Neoplasms

Share to Proto-Oncogene Proteins c-bcl-2

Source

Identifiers

PMID: 12821128
DOI: 10.1016/s0006-291x(03)01072-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Truncated Bcl-2, a potential pre-metastatic marker in prostate cancer.PMID 12821128Read ↗

BCL2 expression is enriched in advanced prostate cancer with features of lineage plasticitySemantic proximity Read ↗

Chemosensitization of Prostate Cancer by Modulating Bcl-2 Family ProteinsSemantic proximity Read ↗

Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers.Semantic proximity Read ↗

Downregulation of Human DAB2IP Gene Expression in Prostate Cancer Cells Results in Resistance to Ionizing RadiationSemantic proximity Read ↗

Prognostic relevance of Bcl‐2 overexpression in surgically treated prostate cancer is not caused by increased copy number or translocation of the geneSemantic proximity Read ↗

Chromosome <i>8p</i> Deletions and <i>8q</i> Gains are Associated with Tumor Progression and Poor Prognosis in Prostate CancerSemantic proximity Read ↗

Piwil2 modulates the invasion and metastasis of prostate cancer by regulating the expression of matrix metalloproteinase-9 and epithelial-mesenchymal transitionsSemantic proximity Read ↗

Prognostic significance of Bcl-2 in clinically localized prostate cancer.Semantic proximity Read ↗

Clusterin: a key player in cancer chemoresistance and its inhibitionSemantic proximity Read ↗

Expression of phosphorylated Ser70 of Bcl-2 correlates with malignancy in human colorectal neoplasms.Semantic proximity Read ↗

Bcl-2 Expression as a Predictive Marker of Hormone-Refractory Prostate Cancer Treated with Taxane-Based ChemotherapySemantic proximity Read ↗

Differential gene expression of BCL‐2, ZEB2‑AS1 and BALR‐2 in prostate cancer and benign prostatic hyperplasiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.